Upload
rindang-abas
View
126
Download
3
Embed Size (px)
Citation preview
MEDICAL FACULTY
MUSLIM UNIVERSITY OF INDONESIA
2017
Tutor :
dr. Rachmat Faisal Syamsu, M.Kes
Innal Hamda 11020150019
Amirah Jihan Afry 11020150042
Rindang Cahyani Abas 11020150101
Gita Refina 11020150130
Ftiri Lestari 11020150142
Haerati Hairil 11020150144
Lilis Lestari 11020150152
Andi Mulia Sudirman 11020150154
A man aged 55 years, come to emergency unit with blood diarrhea
complaints. Patients also complain of heartburn. A history of using
medications for arthritic pain in the knee during the last 6 months.
A history of suffering from the DM and irregular treatment.
HEARTBURN
• Is retrosternal burning sensation in the area, which arise suddenly and spread up to the neck ; perhaps with reflux liquid into the mouth is often caused by gastroesophageal reflux
DM
• Is a chronic metabolic disease or disorders withmultiple etiologies characterized by high blood sugarlevels accompanied by impired metabolism ofcarbohydrates, lipids, and proteins as a result ofinsufficiency of insulin function
( Kamus Kedokteran Dorland. Edisi 28. Hal 501)
( Kamus Kedokteran Dorland. Edisi 28. Hal 309)
A man aged 55 years
Blood diarrhea complaints
Patients also complain of heartburn
A history of using
medications for arthritic pain in
the knee
Suffering from the DM and
irregular treatment
QUADRANT & REGIO
OESOPHAGUS
GASTER
DUODENUM
PANCREAS
Digestive system Motility Secretion Digestion Absorpsi
Mouth and saliva Chew Saliva
Amilase
Mukus
Lisozim
Digestion of
carbohydrates begins
The food was not;
some drugs such as
nitroglycerin
Pharynx and
esophagus
Swallow Flawless - -
Stomach Relaxation
receptive;
peristalsis
Gastric juice
• HCl
• Pepsin mucus
• Intrinsic factor
Carbohydrate
digestion continues in
the corpus of the
stomach; protein
digestion begins in
the gastric antrum
The food was not;
some fat soluble
ingredients, such as
alcohol and aspirin
Pancreatic exocrine There is no Pancreatic digestive enzymes
•Trypsin, chymotrypsin,
karboksipeptidase
•Amylase
•Lipase
NaHCO3 liquid secretion of
the pancreas
These pancreatic
enzymes complete the
digestion in the
duodenum lumen
-
• Heartburn is caused by a back-up of stomch acid into the esophagus. When
stomach acid comes into contact with the walls of the esophagus it often
causes a “burning” feeling.
• Certain foods and lifestyle choices can increase the back up of stomach
acid, making symptoms worse.
• The most common cause is due to the use of NSAIDs in the treatment of
artritisreumatoid and osteoartris. The use of NSAIDs (eg, aspirin,
piroxicam, ibuprofen, meloxicam, celecoxib, trisalicylate etc.), have a
direct effect on the gastric mucosa and causes the formation of ulcers. may
be caused because the destruction of one of the protective barrier in the
stomach.
NSAIDs can cause stomach ulcers through two ways:
a. Irritate the stomach epithelium directly
b. Through inhibiting the synthesis of prostaglandins.
However, the inhibition of prostaglandin synthesis is the dominant factor
that causes peptic ulcers by NSAIDs. Prostaglandins are compounds that
disentsis in the gastric mucosa that protects the body's physiological
functions such as renal function, homeostasis and gastric mucosa.
Based on the literature, the mechanisms involved still unknown but is
thought inhibited production of prostaglandins in the stomach so that the
protection of the gastric mucosa decreases and increases the risk of peptic
ulcers.
• The impact of the inhibition of COX- 1 is the reduction of prostaglandin synthesis so that the physiological
regeneration of the gastric mucosa becomes blocked.
• Long-term NSAID use cause local irritation of the gastric mucosa becomes longer and more intense. So the
gastric mucosa which originally was either be damaged or the gastric mucosa that is damaged can be
bleeding.
• Inhibition of COX-1 would result in a decrease in production tromboxan, followed by the extension of the
blood clotting time ease of bleeding.
• COX-2 inhibitor celecoxib, and other nimesulid experimentally not interfere with blood clotting. Along
with the growing process of vasoconstriction, increased blood clotting due to the more independent of
COX-1 pathway in synthesizing tromboxan will facilitate the occurrence of heart attack in users of
NSAIDs with inhibition of COX-2 which is highly selective.
• Inhibition of prostaglandin biosynthesis in the kidneys causing disruption of homeostasis. In patients with
hypovolemia, heart failure, hepatic cirrhosis, blood flow and filtration rate glomerolus Gijal will be
reduced, even acute renal failure can occur.
• Diabetes Mellitus patients with decreased insulin levels. Insulin plays a
role in stimulating the synthesis of bone matrix and cartilage formation. In
addition, insulin is also very important in normal bone mineralization, and
stimulate the production of IGF-1 by the liver.
• The role of insulin on matrix synthesis, especially in osteoblast
differentiation and function of IGF-1 increases the number of cells that can
synthesize the bone matrix.
• IGF-1 stimulating the synthesis of collagen matrix and bone, stimulate the
replication of cells derived osteoblasts and decreased bone collagen
degradation.
• So that a decrease in insulin levels lead to production of IGF I declined
which is a growth factor that plays a role in the process of cartilage repair.
Thus, there is an imbalance between the formation and bone breakdown
which affects the risk of osteoarthritis.
• Therefore, to reduce the pain experienced or lowers blood glucose levels,
patients taking medications such as allopurinol rheumatic NSAIDs,
medicines urikosirik, indomesatisin, or colchicine and corticosteroids and
ACTH hormone drugs.
• The drugs can inhibit the secretion of prostaglandins in the intestine and
stomach that can cause erosion, ulceration and even perforation of the
organ so that it can cause bleeding issued through the mechanism of
vomiting and defecation mechanism.
ETIOLOGY
PEPTIC ULCER DISEASE
• Damage to the mucosal or submucosal layer until the muscle layer of the GI tract due to the activity of pepsin and excessive stomach acid
GASTRITIS
• The state of inflammation or inflammatory process in the gastric mucosa and submucosa
ULCERATIVE COLITIS
• A chronic inflammatory disease of the intestine (Inflammatory bowel disease) causes inflammation and ulcers continuously on the innermost layer of the colon and rectum. Ulcerative colitis rarely affects the small intestine.
DEFINITION
GEJALA
PEPTIC ULCER DISEASE
• Helicobacter pylori
• The secretion of bicarbonate
• Feature genetic
• Stress
• NSAIDs
GASTRITIS
• Drugs - NSAIDs, such as aspirin, ibuprofen
• Potent alcoholic beverages
• Bacterial infections - H pylori (most frequent)
• Viral infections (eg, CMV)
• Fungal infections - Candidiasis, histoplasmosis, phycomycosis
• Parasitic infection (eg, anisakidosis)
• Acute stress (shock)
• Radiation
• Allergy and food poisoning
• Bile: The reflux of bile
• Ischemia
• Direct trauma
ULCERATIVE COLITIS
• Etiology is unknown, but the disease has a multifactorial and polygenic causes.
ETIOLOGY
GEJALA
PEPTIC ULCER DISEASE
• The most common symptom is burning pain
• The pain often occurs between meals and sometimes awakens people from sleep.
• May last minutes to hours
• Relieved by eating, taking antacids or acid blockers.
• include nausea, vomiting and loss of appetite and weight, and bleeding.
GASTRITIS
• Heartburn, anorexia, belching, nausea, vomiting, bleeding and hematemesis
ULCERATIVE COLITIS
• The predominant symptom is diarrhea, which can be associated with frank blood in the stool.
• Other symptoms : abdominal or rectal pain, fever and weight loss. Although
• Some patients may complain of constipation and rectal spasm.
CLINICAL MANIFESTATION
GEJALA
PEPTIC ULCER DISEASE
• In 70 percent of patients it occurs between the ages of 25 and 64 years
• Lifetime prevalence of PUD in the United States is ~12% in men and 10% in women.
• Moreover,an estimated 15,000 deaths per year occur as a consequence of complicated PUD.
GASTRITIS
• In developing countries the prevalence of Helicobacter pylori infection in adults is 90% whereas in children pravelensi Helicobacter Pylori infection is higher
ULCERATIVE COLITIS
• Most common between 15 and 40 years of age,
• with a second peak in incidence between 50 and 80 years.
• The disease affects men and women at similar rates.
• Studies indicate a decreased risk of ulcerative colitis for current smokers, however, former smokers are at increased risk of developing the disease.
EPIDEMIOLOGY
GEJALA
PEPTIC ULCER DISEASE
• Injury atthe mucosa as a result ofthe topical encounter with NSAIDs.NSAIDs are weak acids thatremain in a nonionized lipophilicform when found within the acidenvironment of the stomach.NSAIDs migrate across lipidmembranes of epithelial cells,leading to cell injury once trappedintracellularly in an ionized form.
• Topical NSAIDs can also alter thesurface mucous layer, permittingback diffusion of H+ and pepsin,leading to further epithelial celldamage.
GASTRITIS
• Helicobacter pylori attached to the gastric epithelium and destroy the protective mucous layer, leaving the epithelial area deforested
• Disrupt the gastric mucosal barrier
ULCERATIVE COLITIS
• There are three major hypotheses as tothese antigenic triggers. One hypothesisis that these triggers are microbialpathogens, as yet unidentified. Accordingto this theory, the immune response inUC is an appropriate but ineffectiveresponse to these pathogens. Thesecond hypothesis as to the antigenictrigger in UC is that there is somecommon dietary antigen ornonpathogenic microbial agent to whichthe patient mounts an abnormal immuneresponse. In UC, the immune cells ofthe lamina propria are exposed tonumerous luminal antigens. Theseluminal antigens are capable of triggeringimmune responses. As a result, specificimmune responses to the etiologicalagent may be overwhelmed by immuneresponses to thousands of luminalantigens that pass through the damagedepithelium.
PATOGENESIS
GEJALA
PEPTIC ULCER DISEASE
• Antacids
• Diet
• Anticholinergic
• Inhibiting H2 (cimetidine, ranitidine, famotidine)
• Anti-microbial therapy
• antibacterial
• Surgery: vagotomi, antrektomi, gastrectomy
GASTRITIS
• Antacids, such as aspirin, sodium bicarbonate, and citric acid (Alka-Seltzer); alumina and magnesia (Maalox); and calcium carbonate and magnesia (Rolaids). Antacids relieve mild heartburn or dyspepsia by neutralizing acid in the stomach.
• Histamine 2 (H2) blockers, such as famotidine and ranitidine. H2 blockers decrease acid production.
• Proton pump inhibitors (PPIs), such as omeprazole, lansoprazole, pantoprazole. PPIs decrease acid production more effectively than H2 blockers.
ULCERATIVE COLITIS
• Diet and supportive therapy
• The choice of drugs depending on the degree of disease. In mild to moderate cases can be administered 5-ASA (aminosalicylic acid) whereas in the case of complicated joints (arthritis) can be administered orally at a dose sulfasalazine gradually.
• Surgery. Surgical indications necessary if found no cases of drug response (cyclosporine) or cases with life-threatening complications, such as megacolon, perforation, ileus obstruction / paralytic ileus, and intestinal bleeding extensively.
MANAGEMENT
GEJALA
PEPTIC ULCER DISEASE
• Pola Healthy living and adequate rest, avoid excessive stress
• Quit smoking
• Modification of diet
GASTRITIS
• Set the feeding schedule
• Avoid greasy foods, sour and spicy
• Reduce alcohol
• Control stress
ULCERATIVE COLITIS
• Psychotherapy is sometimes necessary to prevent psychological stress. Avoid cigarettes and set the pattern for a healthier life
• A special diet is not required, it may be necessary to avoid cabbage and onions because many contain
PREVENTION
GEJALA
PEPTIC ULCER DISEASE
• If the underlying cause of peptic ulcer is resolved, it will provide a good prognosis.
• Most people recover with treatment of H. pylori infection, avoid taking NSAIDs and anti sekretorus in the stomach.
• Treatment with H.pylori infection will change the scientific history of the disease by lowering the incidence of this disease.
GASTRITIS
• If the underlying cause of gastritis is resolved, it will provide a good prognosis
• Many are cured with therapy Helicobacter and avoid NSAIDs
ULCERATIVE COLITIS
• Pretty much reported remisis spontaneous and in the long term. Prognosis influenced by the presence or absence of complications or the level of response to conservative treatment.
PROGNOSIS
GEJALA
PEPTIC ULCER DISEASE
• Penetration, perforation, bleeding and blockages
GASTRITIS
• Gastric Ulcers
• Bleeding in the stomach
• Gastric cancer
ULCERATIVE COLITIS
• Bleeding and toxic megacolon
COMPLICATION
PHYSICAL FEATURES OF DIAGNOSTIC
LABORATORY
Complete blood cell (CBC)
Liver and kidney function tests
Gallbladder and pancreatic
function tests
Stool for blood
RADIOLOGY
Abdominal XRay
Barium meal
CT-scan, MRI
USG
A HISTORY FROM IMAM MUSLIM IN HIS SHAHIH (NO. 2032) :
Told us yahya bin yahya, abu mu’awiya preach to us from Hisham ibn Urwah from Abdurrahman bin Sa’d of Ka’b bin Malik of a fatrher who said, “ The messenger
sallalahu ‘alaihi wa sallam was eaten by using three fingers, and licking the finger, before bringing it down”
ثنا يحيى بن يحيى، أخبرنا أبو مع بد اوية، عن هشام بن عروة، عن ع حد
حمن بن سعد، عن ابن كعب بن مالك، كان رسول »: عن أبيه، قال الر
يد قبل أ هللا صلى هللا عليه وسلم يأكل بثلث ، ويلع ن يمسحها أصاب »
THERE IS A HISTORY OF ABU HASAN BIN AL-MURQI IN SYAMAILNYA AS MENTIONED IN AL-
IHYA TAKHRIJ WORK OF AL-IRAQI (1/432)
عام استوفز على ركبته الي سرى وأقام اليمنىكان إذا قعد على الط
“That (the prophet shallalahu ‘alaihi wassalamu) when he sat down to eat
his knees left and uphold the right food”
See you in the next panel